726 related articles for article (PubMed ID: 15504940)
1. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effect of hepatocyte growth factor in chronic kidney disease: targeting the inflamed vascular endothelium.
Gong R; Rifai A; Dworkin LD
J Am Soc Nephrol; 2006 Sep; 17(9):2464-73. PubMed ID: 16885407
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
Mezzano S; Aros C; Droguett A; Burgos ME; Ardiles L; Flores C; Schneider H; Ruiz-Ortega M; Egido J
Nephrol Dial Transplant; 2004 Oct; 19(10):2505-12. PubMed ID: 15280531
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effect of Y-27632 on chronic allograft nephropathy in rats.
Liu M; Gu M; Wu Y; Zhu P; Zhang W; Yin C; Zhang WJ
J Surg Res; 2009 Nov; 157(1):e117-27. PubMed ID: 19589538
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of nuclear factor-kappaB inhibition in the renal protective effect of oral adsorbent AST-120 in a rat model of chronic renal failure.
Komiya T; Miura K; Tsukamoto J; Okamura M; Tamada S; Asai T; Tashiro K; Kuwabara N; Iwao H; Yoshikawa J
Int J Mol Med; 2004 Jan; 13(1):133-8. PubMed ID: 14654984
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor stimulates the induction of cytokine-induced neutrophil chemoattractant through the activation of NF-kappaB in rat hepatocytes.
Kaibori M; Yanagida H; Nakanishi H; Ozaki T; Yoshida H; Matsui K; Hijikawa T; Kamiyama Y; Okumura T
J Surg Res; 2006 Jan; 130(1):88-93. PubMed ID: 16271365
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine stimulates monocyte chemoattractant protein-1 expression in the kidney via nuclear factor-kappaB activation.
Hwang SY; Woo CW; Au-Yeung KK; Siow YL; Zhu TY; O K
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F236-44. PubMed ID: 17977907
[TBL] [Abstract][Full Text] [Related]
9. Endogenous hepatocyte growth factor attenuates inflammatory response in glycerol-induced acute kidney injury.
Homsi E; Janino P; Amano M; Saraiva Camara NO
Am J Nephrol; 2009; 29(4):283-91. PubMed ID: 18824844
[TBL] [Abstract][Full Text] [Related]
10. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
Ho AW; Wong CK; Lam CW
Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
[TBL] [Abstract][Full Text] [Related]
12. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
13. Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy.
Wang SN; LaPage J; Hirschberg R
Kidney Int; 2000 Mar; 57(3):1002-14. PubMed ID: 10720953
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
Wong CK; Tsang CM; Ip WK; Lam CW
Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction.
Vieira JM; Mantovani E; Rodrigues LT; Dellê H; Noronha IL; Fujihara CK; Zatz R
Nephrol Dial Transplant; 2005 Aug; 20(8):1582-91. PubMed ID: 15855201
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective effects of paricalcitol on gentamicin-induced kidney injury in rats.
Park JW; Bae EH; Kim IJ; Ma SK; Choi C; Lee J; Kim SW
Am J Physiol Renal Physiol; 2010 Feb; 298(2):F301-13. PubMed ID: 19940033
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis.
Ruiz-Ortega M; Bustos C; Hernández-Presa MA; Lorenzo O; Plaza JJ; Egido J
J Immunol; 1998 Jul; 161(1):430-9. PubMed ID: 9647253
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
19. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways.
Liu Y; Rajur K; Tolbert E; Dworkin LD
Kidney Int; 2000 Nov; 58(5):2028-43. PubMed ID: 11044223
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease.
Mizuno S; Kurosawa T; Matsumoto K; Mizuno-Horikawa Y; Okamoto M; Nakamura T
J Clin Invest; 1998 May; 101(9):1827-34. PubMed ID: 9576745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
